Survival of advanced Non Small Cells Lung Cancer patients treated with EGF therapeutic vaccine compared with conventional treatment.

Trial Profile

Survival of advanced Non Small Cells Lung Cancer patients treated with EGF therapeutic vaccine compared with conventional treatment.

Suspended
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs BV NSCLC 001 (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Feb 2016 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research
    • 24 Oct 2013 New source identified and integrated: Cuban Clinical Trial Registry record.
    • 27 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top